AD-115A, AD-1151

DRUG2 trials

Sponsors

Addpharma Inc.

Conditions

Gastric Ulcer

Phase 1

The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'

CompletedNCT06902818

Addpharma Inc.Gastric Ulcer

Start: 2025-03-21End: 2025-05-08Updated: 2025-10-03

Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'

RecruitingNCT07385235

Addpharma Inc.Gastric Ulcer

Start: 2026-01-27End: 2026-03-16Target: 46Updated: 2026-02-11